Furthermore, glycosphingolipid synthase B4GALNT1, which has previously been associated with neuro-tumor progression and cancer stem cell characteristics by affecting glycosphingolipids, was upregulated in the high-abundance group [34,35]. The gene discussed is B4GALNT1; the disease is cancer.